| Literature DB >> 27476424 |
Victor S Gehling1, Steven F Bellon2, Jean-Christophe Harmange2, Yves LeBlanc2, Florence Poy2, Shobu Odate2, Shane Buker2, Fei Lan2, Shilpi Arora2, Kaylyn E Williamson2, Peter Sandy2, Richard T Cummings2, Christopher M Bailey2, Louise Bergeron2, Weifeng Mao3, Amy Gustafson4, Yichin Liu4, Erica VanderPorten4, James E Audia2, Patrick Trojer2, Brian K Albrecht2.
Abstract
This communication describes the identification and optimization of a series of pan-KDM5 inhibitors derived from compound 1, a hit initially identified against KDM4C. Compound 1 was optimized to afford compound 20, a 10nM inhibitor of KDM5A. Compound 20 is highly selective for the KDM5 enzymes versus other histone lysine demethylases and demonstrates activity in a cellular assay measuring the increase in global histone 3 lysine 4 tri-methylation (H3K4me3). In addition compound 20 has good ADME properties, excellent mouse PK, and is a suitable starting point for further optimization.Entities:
Keywords: Epigenetics; Histone lysine demethylase; JARID1; KDM5
Mesh:
Substances:
Year: 2016 PMID: 27476424 DOI: 10.1016/j.bmcl.2016.07.026
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823